| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 02/10/2000 | WO2000006529A1 Diketoacid-derivatives as inhibitors of polymerases |
| 02/10/2000 | WO2000006525A2 Synthesis of combinatorial libraries of compounds reminiscent of natural products |
| 02/10/2000 | WO2000006149A1 Sulfonamide derivatives |
| 02/10/2000 | WO2000006137A2 Glucocorticoid-selective anti-inflammatory agents |
| 02/10/2000 | WO2000006085A2 Compounds and methods |
| 02/10/2000 | WO2000000489A3 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands |
| 02/10/2000 | WO1999063939A3 Multibinding inhibitors of cyclooxygenase-2 |
| 02/10/2000 | WO1999030548A3 Method for the preparation of citalopram |
| 02/10/2000 | DE19835324A1 Cyclopentabenzofuran-Derivate und ihre Verwendung Cyclopentabenzofuran derivatives and their use |
| 02/10/2000 | CA2339099A1 Sulfonamide derivatives |
| 02/10/2000 | CA2338697A1 Compounds and methods |
| 02/10/2000 | CA2338490A1 Diketoacid-derivatives as inhibitors of polymerases |
| 02/10/2000 | CA2335077A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/09/2000 | EP0977746A1 Process for the production of tetrahydrofuran and gammabutyrolactone |
| 02/09/2000 | EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 02/09/2000 | EP0788494B1 Process for the preparation of furosemide |
| 02/09/2000 | CN1244197A Tetrahydrofuran derivatives |
| 02/09/2000 | CN1243831A Preparation of cyclopropane derivatives with anti-virus effectiveness and intermediate therefor |
| 02/09/2000 | CN1243820A Method for producing aromatic carboxylic acid |
| 02/08/2000 | US6022996 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 02/08/2000 | US6022984 Efficient synthesis of furan sulfonamide compounds useful in the synthesis of new IL-1 inhibitors |
| 02/08/2000 | US6022872 α- and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 02/03/2000 | WO2000005402A1 Continuous process for preparing optically pure (s)-3,4-dihydroxybutyric acid derivatives |
| 02/03/2000 | WO2000005401A1 Continuous process for preparing optically pure (s)-3-hydroxy-gama-butyrolactone |
| 02/03/2000 | WO2000005400A1 Process for preparing optically pure (s)-3,4-dihydroxybutyric acid derivatives |
| 02/03/2000 | WO2000005399A1 Process for preparing optically pure (s)-3-hydroxy-gama-butyrolactone |
| 02/03/2000 | WO2000005398A1 Process for preparing alpha-(1,4) linked oligosaccharide |
| 02/03/2000 | WO2000005198A1 Anthranilic acid derivatives |
| 02/03/2000 | WO2000005184A1 Method for hydrogenating unsaturated heterocyclic compounds |
| 02/03/2000 | WO2000004893A2 Imidazoline receptor binding compounds |
| 02/03/2000 | WO2000004892A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 02/03/2000 | WO1999067232A3 Process for the preparation of 3-aryl-benzofuranones |
| 02/03/2000 | DE19934952A1 New cyclopenta-benzofuran derivatives, used as pesticides, especially insecticides and acaricides for plant protection |
| 02/03/2000 | DE19834751A1 Disubstituierte bicyclische Heterocyclen, ihre Herstellung und ihre Verwendung als Arzneimittel Disubstituted bicyclic heterocycles, their preparation and their use as medicaments |
| 02/03/2000 | CA2338757A1 Continuous process for preparing optically pure (s)-3,4-dihydroxybutyric acid derivatives |
| 02/03/2000 | CA2338756A1 Continuous process for preparing optically pure (s)-3-hydroxy-gama-butyrolactone |
| 02/03/2000 | CA2338755A1 Process for preparing alpha-(1,4) linked oligosaccharide |
| 02/03/2000 | CA2338752A1 Process for preparing optically pure (s)-3,4-dihydroxybutyric acid derivatives |
| 02/03/2000 | CA2338527A1 Process for preparing optically pure (s)-3-hydroxy-gama-butyrolactone |
| 02/03/2000 | CA2338279A1 Imidazoline receptor binding compounds |
| 02/03/2000 | CA2335062A1 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 02/02/2000 | EP0976818A1 Use of glycin-N,N-diacetic acid derivatives as biodegradable complexing agents for alkaline earth and heavy metal ions, in compact powder-, ultra compact powder- and liquid-detergentcompositions |
| 02/02/2000 | EP0976742A1 A synthesis of furan sulfonamide compounds useful in the synthesis of IL-1 inhibitors |
| 02/02/2000 | EP0975622A1 Selective olefin metathesis of bifunctional or polyfunctional substrates in compressed carbon dioxide as reaction medium |
| 02/02/2000 | EP0975617A1 Inhibitors of cholesterol esterase |
| 02/02/2000 | EP0975614A1 A bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5ht1a, 5ht1b and 5ht1d receptor antagonistic activity |
| 02/02/2000 | EP0975587A1 Oxime ether compounds, their use and intermediates for preparations of the same |
| 02/02/2000 | EP0975586A2 Oxime compounds, their use, and intermediates for their production |
| 02/02/2000 | CN1243441A Cervical maturing agent |
| 02/02/2000 | CN1243126A Method for preparing asymmetric lactone |
| 02/02/2000 | CN1048984C Preparation of crystal form 1 furaniramine hydrochloride |
| 02/01/2000 | US6020533 Hydrocarbon conversion processes using crystalline manganese phosphate compositions |
| 02/01/2000 | US6020525 (2S,2'R,3'R)-2-(2,3-dicarboxyl-cyclopropyl)-glycine (DCG-1/4) and 3 H-DCG-1/4 and to process for the preparation thereof |
| 02/01/2000 | US6020502 Preparation of fluorinated dicarbonyls |
| 02/01/2000 | US6020501 Process for preparing phthalides |
| 02/01/2000 | US6020500 Hydroxy-substituted monolactones useful as intermediates for preparing lubricating oil and fuel additives |
| 02/01/2000 | US6020488 Small molecule inhibition of RNA/ligand binding |
| 02/01/2000 | US6020368 Microbiocides |
| 02/01/2000 | US6020366 Butyric acid matrix metalloproteinase inhibitors |
| 02/01/2000 | US6020365 Anticancer agents; antitumor agents |
| 02/01/2000 | US6020343 (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors |
| 02/01/2000 | US6020339 Aryl furan derivatives as PDE IV inhibitors |
| 01/27/2000 | WO2000004023A1 Anhydride modified cantharidin analogues useful in the treatment of cancer |
| 01/27/2000 | WO2000003979A1 Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments |
| 01/27/2000 | WO2000003978A2 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same |
| 01/27/2000 | WO2000003976A1 Imidamide derivatives |
| 01/27/2000 | WO2000003975A2 Aryl vinyl ether derivatives and their use as herbicides |
| 01/27/2000 | WO1999065888A3 A reference compound for use in the analysis of levosimendan batches |
| 01/27/2000 | WO1999058527A3 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient |
| 01/27/2000 | WO1999058477A3 N-[3-[2-[(2,3-dihydro-1h-inden-2-yl)alkylamino]-ethyl]phenyl carboxamide derivatives, preparation and therapeutic applications |
| 01/27/2000 | DE19832810A1 Hydrogenation of unsaturated heterocyclic compounds, especially pyridine compounds, uses a catalyst containing a Subgroup VIII metal on a macroporous support |
| 01/27/2000 | CA2337773A1 Imidamide derivatives |
| 01/27/2000 | CA2337771A1 Anhydride modified cantharidin analogues useful in the treatment of cancer |
| 01/26/2000 | EP0974579A1 Novel nitroisourea derivatives |
| 01/26/2000 | EP0974572A1 Novel process for producing alcohols |
| 01/26/2000 | EP0973760A1 Kodaistatins a, b, c and d, a process for their production and their use |
| 01/26/2000 | EP0973735A2 Polyaromatic antiviral compositions |
| 01/26/2000 | EP0973512A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/26/2000 | EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 01/26/2000 | EP0973390A1 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease |
| 01/26/2000 | EP0778834B1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 01/26/2000 | EP0670677B1 Potentiator of Bacillus pesticidal activity |
| 01/26/2000 | EP0643051B1 Process for Producing Alfa, Beta-Unsaturated Ketones |
| 01/26/2000 | CN1242364A Red sage root extract for treating peptic gastric ulcer, and process for preparing same |
| 01/26/2000 | CN1048725C Nicotinic acid derivatives and herbicide |
| 01/26/2000 | CN1048720C New O-arylmethyl-N-(thio) acylhydroxylamines, prepn. method and pharmaceutical compositions thereof |
| 01/26/2000 | CN1048719C Novel 7-(substituted)-8-(substituted)-9-(substituted amino)-6-demethyl-6-deoxytetracyclines, prepn. method, their compositions and use thereof |
| 01/25/2000 | US6018050 Enantiomerically pure compounds obtained in high yields; preparing sterically demanding amino acids and their derivatives, such as the preparation of cis-4-hydroxyproline precursors; asymmetric synthesis |
| 01/25/2000 | US6017956 N,N-disubstituted amic acid derivatives |
| 01/25/2000 | US6017953 Treating ocular hypotension, hypertension, hemorrhage, myocardial ischemia, angina pectoris, coronary contraction, cerebrovascular contraction after subarachnoidal hemorrhage, and asthma |
| 01/25/2000 | US6017951 Butenolide endothelin antagonists |
| 01/25/2000 | US6017947 Heterocyclic carbodithioperoxyimidic compounds useful for the inhibition of the replication of HIV |
| 01/25/2000 | US6017928 Retroviral protease inhibiting compounds |
| 01/25/2000 | US6017918 Phenyl glycine compounds and methods of treating atherosclerosis and restenosis |
| 01/25/2000 | US6017916 Nonpeptide endothelin antagonists I |
| 01/20/2000 | WO2000002887A2 Ligands for metals and metal-catalyzed processes |
| 01/20/2000 | WO2000002874A2 Integrin dependent cell adhesion inhibitors |
| 01/20/2000 | WO2000002850A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 01/20/2000 | WO2000002836A1 Method for preparing 2-disubstituted 2,3-dihydrobenzofuran derivatives |
| 01/20/2000 | WO1999059526A3 Protease inhibitors |